logo
Select company
Select metric
3.24Cash Ratio
VS
Market
88
Sector
77
Industry
67
History
45
$ 11.1Close
$ 7.4 - $ 16.01 52-Week Range
Ticker Information

Ticker

KALV

Company Name

KALVISTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KALVISTA PHARMACEUTICALS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KALV - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 124.3M3.24$ 38.38M
3/31/2025$ 131.62M2.91$ 45.17M
12/31/2024$ 167.29M6.53$ 25.61M
9/30/2024$ 41.58M1.88$ 22.16M
6/30/2024$ 31.85M1.42$ 22.41M
3/31/2024$ 31.79M1.39$ 22.81M
12/31/2023$ 23.06M1.21$ 19.13M
9/30/2023$ 57.67M3.25$ 17.75M
6/30/2023$ 49.41M3.5$ 14.13M
3/31/2023$ 56.24M3.74$ 15.03M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KALVISTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cash Ratio stands at 1.7.
  • Over the past 5 years, KALVISTA PHARMACEUTICALS INC's average Cash Ratio has been 3.56.
  • The median Cash Ratio for KALVISTA PHARMACEUTICALS INC during this period was 3.33
  • KALVISTA PHARMACEUTICALS INC reached its highest Cash Ratio over the past 5 years at 7.33.
  • The lowest Cash Ratio recorded by KALVISTA PHARMACEUTICALS INC in the same timeframe 1.21

KALVISTA PHARMACEUTICALS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
INBX : INHIBRX BIOSCIENCES INC 4.79PROK : PROKIDNEY CORP 3.01NWBO : NORTHWEST BIOTHERAPEUTICS INC 0.05ATAI : ATAI LIFE SCIENCES NV 2.42SEPN : SEPTERNA INC 12.57OTLK : OUTLOOK THERAPEUTICS INC 0.28RNAC : CARTESIAN THERAPEUTICS INC 13.08PLUR : PLURI INC 0.2CLSD : CLEARSIDE BIOMEDICAL INC 3.08IGC : IGC PHARMA INC 0.39

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for KALVISTA PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 16.17M ] / LiabilitesC [ $ 9.54M ]
(=) Cash Ratio [ 1.7 ]

KALV - Cash Ratio, Last 5 years

1.21

Minimum

Dec 31, 2023

7.33

Maximum

Dec 31, 2022

3.56

Average

3.33

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63